Join the club for FREE to access the whole archive and other member benefits.

Psilocybin in magic mushrooms to treat major depressive disorder

08-Jun-2020

Key points from article :

Psilocybin seems to give better results than escitalopram for major depressive disorder.

Psilocybin-assisted therapy involves patient assessment, preparation and supported dosing sessions.

The whole process is psychologically supported and talks through patient's experience afterwards.

Patients felt emotionally and physically recalibrated, clear-sighted and calm.

Psychedelics increase brain “plasticity” and accommodates an accelerated ability to change.

Plans to get psilocybin therapy licensed and market it within the next five years.

59 participants took part in this randomised double-blind clinical trial.

Research by Centre for Psychedelic Research at Imperial College London.

But psychedelics are definitely dangerous in larger, unregulated doses

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Academia

Centre for Psychedelic Research based in Hammersmith Hospital Campus, Imperial College London

Academia

Public research university with an international reputation for excellence in teaching and research

Academic

Head of Imperial Psychedelic Research Group at Imperial College London.